3 oxo C12 BSA (50 ug/ml)3oxo C12 BSA (100 ng/ml)3 oxo C12 BSA (100 ng/ml)TEA Elution (100 mM)TEA Elution (100 mM)TEA Elution (100 mM)TEA Elution (100 mM)TEA Elution (100 mM)TEA Elution (100 mM)N-acyl C12 BSA (5 ug/ml)N-acyl C12 BSA (5 ug/ml)N-acyl C12 BSA (100 ng/ml)FA Elution – 1 μM 30H C12FA Elution – 10 nM 3oxo C12FA Elution – 1 μM 3oxo C123OH C12 BSA (50 μg/ml)FA Elution – 10 μM C4-HSL FA Elution – 10 μM C4-HSLPan 1Pan 2Pan 3Strategy 2Strategy 1Pan 1Pan 2Pan 3Fig. 2Outline of the panning strategy adopted for the selection of cross-reactive anti-HSL clones
Monoclonal Antibodies Inactivating AHL Signal Molecules 345